17.65
전일 마감가:
$17.81
열려 있는:
$17.57
하루 거래량:
254.66K
Relative Volume:
0.49
시가총액:
$786.22M
수익:
$159.01M
순이익/손실:
$-21.72M
주가수익비율:
-33.94
EPS:
-0.52
순현금흐름:
$-20.63M
1주 성능:
-6.06%
1개월 성능:
-11.74%
6개월 성능:
+24.89%
1년 성능:
+126.12%
Axogen Inc Stock (AXGN) Company Profile
명칭
Axogen Inc
전화
(386) 462-6817
주소
13631 PROGRESS BLVD., ALACHUA, FL
AXGN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
AXGN
Axogen Inc
|
17.66 | 786.22M | 159.01M | -21.72M | -20.63M | -0.52 |
![]()
ABT
Abbott Laboratories
|
131.59 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.09 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
376.25 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.57 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.79 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-17 | 개시 | Lake Street | Buy |
2024-07-01 | 개시 | Raymond James | Outperform |
2022-11-11 | 재개 | Jefferies | Buy |
2022-05-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2022-03-11 | 재개 | Cantor Fitzgerald | Overweight |
2020-10-23 | 개시 | Guggenheim | Buy |
2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
2020-05-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2020-04-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2019-07-12 | 개시 | Canaccord Genuity | Buy |
2018-03-02 | 재확인 | Lake Street | Buy |
2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
2017-11-30 | 개시 | Jefferies | Buy |
2017-11-21 | 재확인 | Lake Street | Buy |
2017-07-31 | 개시 | Leerink Partners | Outperform |
2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
2017-03-06 | 개시 | ROTH Capital | Buy |
2016-11-22 | 업그레이드 | Lake Street | Hold → Buy |
2016-11-07 | 재확인 | Wedbush | Outperform |
2016-11-03 | 다운그레이드 | Lake Street | Buy → Hold |
2016-08-04 | 재확인 | Wedbush | Outperform |
2014-05-14 | 개시 | Dawson James | Buy |
2013-10-31 | 재확인 | Ladenburg Thalmann | Buy |
모두보기
Axogen Inc 주식(AXGN)의 최신 뉴스
(AXGN) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Shareholders Should Be Pleased With Axogen, Inc.'s (NASDAQ:AXGN) Price - Simply Wall St
PNC Financial Services Group Inc. Decreases Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen: LT Bullish, But Outcomes Weighted To Downside At This Point (NASDAQ:AXGN) - Seeking Alpha
Charles Schwab Investment Management Inc. Has $6.87 Million Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen appoints Rick Ditto as VP, global health economics, reimbursment & policy - TipRanks
Axogen Announces Appointment of Rick Ditto as Vice - GlobeNewswire
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Bank of New York Mellon Corp Trims Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen’s chief innovation officer sells $264,442 in shares - Investing.com India
AxoGen, Inc. (NASDAQ:AXGN) Receives $20.75 Average Target Price from Brokerages - Defense World
US Bancorp DE Makes New $30,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen’s chief innovation officer sells $264,442 in shares By Investing.com - Investing.com UK
Lake Street Initiates Coverage of Axogen (LSE:0HKD) with Buy Recommendation - Nasdaq
AxoGen (NASDAQ:AXGN) Now Covered by Lake Street Capital - Defense World
Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - Nasdaq
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Lake Street starts AxoGen stock with Buy, sets $30 target By Investing.com - Investing.com Canada
Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75% - Yahoo Finance UK
Lake Street starts AxoGen stock with Buy, sets $30 target - Investing.com
Lake Street Initiates Axogen at Buy With $30 Price Target -March 17, 2025 at 08:17 am EDT - Marketscreener.com
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Canada
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com
Cantor maintains AxoGen stock target at $24, bullish on growth plan - Investing.com Australia
Cantor maintains AxoGen stock target at $24, bullish on growth plan By Investing.com - Investing.com South Africa
(AXGN) Technical Data - Stock Traders Daily
Principal Financial Group Inc. Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for AxoGen (NASDAQ:AXGN) - Defense World
Rhumbline Advisers Has $960,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen director Amy McBride sells $100,100 in stock By Investing.com - Investing.com Canada
Insider Sell: Amy Wendell Sells 5,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Axogen director Amy McBride sells $100,100 in stock - Investing.com India
Analyst Expectations For Axogen's Future - Nasdaq
Cantor Fitzgerald maintains AxoGen stock overweight rating By Investing.com - Investing.com Australia
AxoGen’s Strategic Growth and Market Positioning: Buy Rating Affirmed by Caitlin Cronin - TipRanks
Cantor Fitzgerald maintains AxoGen stock overweight rating - Investing.com India
Citizens JMP reiterates AxoGen stock with $26 target By Investing.com - Investing.com South Africa
Citizens JMP reiterates AxoGen stock with $26 target - Investing.com
14,285 Shares in AxoGen, Inc. (NASDAQ:AXGN) Bought by Y Intercept Hong Kong Ltd - Defense World
AxoGen’s Strategic Market Positioning and Anticipated BLA Approval Drive Buy Rating - TipRanks
AxoGen Unveils Strategic Priorities for 2025-2028 - TipRanks
AxoGen, Inc. (NASDAQ:AXGN) Shares Purchased by New York State Common Retirement Fund - Defense World
Leerink Partnrs Estimates AxoGen FY2029 Earnings - Defense World
Cantor Fitzgerald Decreases Earnings Estimates for AxoGen - Defense World
FY2025 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald - MarketBeat
AxoGen (NASDAQ:AXGN) Posts Quarterly Earnings Results - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for AxoGen (NASDAQ:AXGN) Stock - Defense World
Axogen Inc (AXGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):